- Home
- CHGG vs PSTX Comparison
CHGG vs PSTX Comparison
Compare CHGG & PSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHGG
- PSTX
- Stock Information
- Founded
- CHGG 2005
- PSTX 2014
- Country
- CHGG United States
- PSTX United States
- Employees
- CHGG N/A
- PSTX N/A
- Industry
- CHGG Other Consumer Services
- PSTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CHGG Real Estate
- PSTX Health Care
- Exchange
- CHGG Nasdaq
- PSTX Nasdaq
- Market Cap
- CHGG 169.0M
- PSTX 249.1M
- IPO Year
- CHGG 2013
- PSTX 2020
- Fundamental
- Price
- CHGG $1.52
- PSTX $2.50
- Analyst Decision
- CHGG Hold
- PSTX Strong Buy
- Analyst Count
- CHGG 10
- PSTX 2
- Target Price
- CHGG $5.31
- PSTX $15.00
- AVG Volume (30 Days)
- CHGG 3.7M
- PSTX 533.7K
- Earning Date
- CHGG 11-12-2024
- PSTX 11-07-2024
- Dividend Yield
- CHGG N/A
- PSTX N/A
- EPS Growth
- CHGG N/A
- PSTX N/A
- EPS
- CHGG N/A
- PSTX N/A
- Revenue
- CHGG $683,338,000.00
- PSTX $88,462,000.00
- Revenue This Year
- CHGG N/A
- PSTX $36.53
- Revenue Next Year
- CHGG N/A
- PSTX N/A
- P/E Ratio
- CHGG N/A
- PSTX N/A
- Revenue Growth
- CHGG N/A
- PSTX N/A
- 52 Week Low
- CHGG $1.48
- PSTX $1.83
- 52 Week High
- CHGG $11.48
- PSTX $4.27
- Technical
- Relative Strength Index (RSI)
- CHGG 39.09
- PSTX 38.80
- Support Level
- CHGG $1.50
- PSTX $2.41
- Resistance Level
- CHGG $1.63
- PSTX $2.61
- Average True Range (ATR)
- CHGG 0.11
- PSTX 0.12
- MACD
- CHGG 0.01
- PSTX -0.01
- Stochastic Oscillator
- CHGG 9.21
- PSTX 24.66
About CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.
About PSTX Poseida Therapeutics Inc.
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.